SCHEMBL470025

SCHEMBL470025

COc1ccccc1NC(=S)N/N=C1\C(=O)Nc2ccc(F)cc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.49
KDR P35968 1/20 0.47
HPGD P15428 1/20 0.46
KMT2A Q03164 4/20 0.46
MAPT P10636 4/20 0.46
MEN1 O00255 3/20 0.46
HTT P42858 1/20 0.46
SMN1; SMN2 Q16637 4/20 0.44
LMNA P02545 3/20 0.44
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 2/20 0.44
LRRK2 Q5S007 3/20 0.44
ALOX12 P18054 2/20 0.42
NPC1 O15118 1/20 0.42
RRM1 P23921 1/20 0.42
RRM2 P31350 1/20 0.42
RAB9A P51151 1/20 0.42
RRM2B Q7LG56 1/20 0.42
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31491968 0.88 KMT2A (0.47) GAAHPGDKMT2AMAPTMEN1
SCHEMBL13008039 0.88 LRRK2 (0.46) GAAKDRKMT2AMAPTMEN1
SCHEMBL13061635 0.87 LRRK2 (0.47) KDRKMT2AMEN1LRRK2NPC1
SCHEMBL31491974 0.84 ALDH1A1 (0.53) GAAHPGDKMT2AMAPTMEN1
SCHEMBL470016 0.83 KDR (0.53) GAAKDRKMT2AMAPTMEN1
SCHEMBL18974994 0.83 LRRK2 (0.52) GAAKDRMAPTALDH1A1LRRK2
SCHEMBL31492045 0.83 LRRK2 (0.52) GAAKDRMAPTALDH1A1LRRK2
SCHEMBL469808 0.82 KDR (0.66) GAAKDRKMT2AMAPTMEN1
SCHEMBL13008097 0.80 KDR (0.54) GAAKDRKMT2AMAPTALDH1A1
SCHEMBL23869703 0.80 KDR (0.49) GAAKDRKMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2240175-B1 COMPOUNDS WITH MDR1-INVERSE ACTIVITY US GOV HEALTH & HUMAN SERV (US) 2013-01-02 EP disclosed
WO-2012033601-A1 THIOSEMICARBAZONES WITH MDR1 - INVERSE ACTIVITY THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) 2012-03-15 WO disclosed
WO-2009102433-A2 COMPOUNDS WITH MDR1-INVERSE ACTIVITY THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2009-08-20 WO disclosed